Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.1.53 (
sialidase
)
2,694
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The influences of different calcium-entry blockers,
sialidase
and
caffeine
on the biphasic contraction induced by prostaglandin (PG) F2 alpha in the feline basilar artery (BA) were studied in calcium-free medium. After incubation in calcium-free solution, PGF2 alpha induced a contraction of the BA amounting to 87% of the contraction in calcium-containing solution. The response was biphasic in 41 out of 42 vessel segments. PGF2 alpha-induced contractions were markedly attenuated in TRIS-buffered solutions as compared to contractions in Krebs solution. PGF2 alpha failed to induce a biphasic contraction (8 out of 9 preparations) in calcium-free HEPES-buffered solution. Calcium entry blockade with 1 mM manganese or 10(-5) M diltiazem abolished the second and major phase of the PGF2 alpha-induced contraction in calcium-free Krebs solution. The second contraction phase was also eliminated in four out of five preparations pretreated with
sialidase
(1 unit/ml for 30 min.), but was unaffected by a brief exposure to 20 mM
caffeine
in calcium-free medium. The present findings strongly support previous suggestions that a major part of the PGF2 alpha-induced contraction in calcium-free medium is mediated via the release of calcium bound to the exterior aspect of the cell membrane.
...
PMID:Cellular calcium and the contraction induced by prostaglandin F2 alpha in feline cerebral arteries. 392 1